| | | | | |
| $43,8800 | -1,46% | $292,68M | $15,09K | |
NUCL Eagle Nuclear Energy Corp. Common stock | $8,8800 | +0,23% | $292,53M | $319,96K | |
BACC Blue Acquisition Corp. Class A Ordinary Shares | $10,8700 | +0,09% | $292,20M | $191,91K | |
FWDI Forward Industries, Inc. Common Stock | $4,7900 | -0,42% | $292,06M | $2,17M | |
ELDN Eledon Pharmaceuticals, Inc. Common Stock | $3,9450 | -0,13% | $291,76M | $1,09M | |
| $10,2700 | +0,69% | $291,70M | $417,31K | |
SVAQ Silicon Valley Acquisition Corp. Class A Ordinary Shares | $10,1100 | +0,40% | $291,56M | $39,22K | |
WNEB Western New England Bancorp, Inc. | $14,4600 | -0,07% | $291,41M | $25,31K | |
| $7,7400 | +0,00% | $291,40M | $68,98K | |
PACH Pioneer Acquisition I Corp Class A Ordinary Shares | $10,2400 | -0,20% | $291,22M | $8,000 | |
MMD NYLI MacKay DefinedTerm Muni Opportunities Fund | $15,4700 | +0,00% | $291,08M | $15,16K | |
AENT Alliance Entertainment Holding Corporation Class A Common Stock | $5,9400 | -0,17% | $291,06M | $7,55K | |
GLSI Greenwich LifeSciences, Inc. | $22,0800 | +0,36% | $290,62M | $91,62K | |
SABS SAB Biotherapeutics, Inc. Common Stock | $3,9200 | +0,00% | $290,56M | $237,73K | |
TLSI TriSalus Life Sciences, Inc. Common Stock | $4,6950 | +0,11% | $290,50M | $99,24K | |
